| Application no. and date | 12733368.0 (espacenet) (Federated) (European Patent Register), 20120626 | | Patent/reg. no. and date | DK/EP 2723722, 20150909 | | Publication date | 20140430 | | Priority no. and date | US 201161501687 P, 20110627, US 201261635745 P, 20120419 | | EP pub. no. and date |
EP 2723722 20140430 | | Effective date | | | Applicant/owner | Parion Sciences, Inc., 2525 Meridian Parkway,
Suite 260
Durham, NC 27713, US | | Applicant ref. no. | P017140EPDK1 EJ/Ve | | Inventor | JOHNSON, Michael, R., c/o Gilead Sciences Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/4965 (2006.01) , A61P 11/00 (2006.01) , C07D 239/48 (2006.01) | | Title | 3,5-DIAMINO-6-CHLOR-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-PENTAHYDROXY-HEXYLAMINO)ETHOXY)PHENYL)BUTYL)CARBAMIMIDOYL)PYRAZIN-2-CARBOXAMID | | Int. application no. | US2012044272 | | Int. publication no. | WO2013003386 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
